Therapeutic Expertise
In Vitro Diagnostic Services - Assist You to Develop a Successful Dx Product
Service options
Clinical Study Design
- Provide input on site selection, inclusion/exclusion criteria, etc.
- Provided input on optimal sample type and collection procedures
- Site selection and evaluation
Patient Enrollment and Sample Collection
- Develop patient enrollment and retention (if applicable) plans
- Provide on site training and monitoring of sample collection
- Determine sample transit and storage logistics
- Monitor patient data
Clinical Data Management
- Build clinical data base and perform biostatistical analysis
- Combining clinical outcome with analytical data to determine clinical validity and utility of Dx test
- Build algorithms for multiplex tests if applicable
Regulatory Submission (European and US)
- Strategic Regulatory Plans -- understanding the road to market
- Investigational Device (IDE) Submissions
- Pre-Market Approval (PMAs) Applications and Pre-Market Notification Submissions (510k’s)
- EC and country authority submissions in Europe
Hua Gong, MD, PhD - IVD Executive Director
- Over 12 years of working experience in developing biomarker /diagnostics tests for Oncology, RA, IBD, IBS, and CNS diseases
- Successfully led multi-million dollar collaborations with pharmaceutical companies in developing companion diagnostics
- Extensive experience in clinical study design for clinical validation and clinical utility studies required for IVD development
- Extensive experience of developing biomarker assays using multiple technology platforms including Protein microarray, genotyping, microRNA profiling, mutation analysis, gene expression profiling, ELISA, MSD, HPLC etc.
- Strong network with KOL in multiple disease areas including oncology, autoimmune and CNS
- Familiar with the requirements for FDA IVD clerance
Supported by team of medical device / IVD experts in Study Start up and submissions team and our dedicated clinical operations group with country based local CRAs in US and Europe.
